Cardiovascular diseases (CVD) are the number one cause of death globally. An estimated 17.3 million people died from CVDs in 2008, representing 30% of all global deaths. Of these deaths, an estimated 7.3 million were due to coronary heart disease. The number of people who die from CVDs will increase to reach 23.3 million by 2030. Coronary artery disease (CAD) is the most common cause of CVD mortality. 1 Cardiovascular diseases are becoming a significant burden on health care services in Bangladesh. 2 With the increase incidence of DM and hypertension, the prevalence of CKD is also alarmingly going up. CKD is strongly associated with accelerated CVDs and this association is independent of conventional risk factors such as DM, hypertension, dyslpidaemia 3 and caused by non-conventional risk factors such as anaemia, altered calcium-phosphorus metabolism, increased homocysteine level, inflammation and oxidative stress. 4 The glomerular filtration rate (GFR), determined by the Cockcroft-Gault equation, is a more precise and accurate way of estimating kidney function than measuring serum creatinine. 5 The United States National Kidney Foundation uses GFR rather than serum creatinine level to define renal dysfunction. National Kidney Foundation recommended estimated GFR for use in recognition, treatment and prevention of chronic kidney disease. It is considered as the overall best indicator of kidney function. Serum creatinine alone fails to identify many patients whose kidney function is reduced. 
The glomerular filtration rate (GFR), determined by the Cockcroft-Gault equation, is a more precise and accurate way of estimating kidney function than measuring serum creatinine. 5 The United States National Kidney Foundation uses GFR rather than serum creatinine level to define renal dysfunction. National Kidney Foundation recommended estimated GFR for use in recognition, treatment and prevention of chronic kidney disease. It is considered as the overall best indicator of kidney function. Serum creatinine alone fails to identify many patients whose kidney function is reduced. For example, an elderly person could lose half of their kidney function before serum creatinine rises above the normal level. 6 Renal function is an important predictor of the presence and severity of angiographic CAD even in patients without severe renal impairment. 7 Early stages of CKD that are characterized by relatively preserved renal function are associated with increasing incidence of de novo and recurrent CVD events. 8 As GFR diminishes the prevalence and severity of CAD increases 9 . Patients with CKD have more severe CAD that's why there is a high rate of cardiovascular events in CKD patients. 10 CVD is the main cause of morbidity and mortality in renal impaired patient. Individuals with CKD are more likely to die of CVD than to develop end-stage renal disease. 11 CVD in renal impaired patients is potentially preventable and treatable.
Materials and methods:
Study population 110 patients of chronic stable angina who got admitted for coronary angiogram into department of cardiology, NICVD from January to October 2013, were selected by purposive sampling for this analytical study. The main objective of the study was to find out the association between impaired renal function and coronary artery disease severity in patients with chronic stable angina. Patients with DM, Cardiomyopathy, Valvular or Congenital heart disease, left ventricular ejection fraction <40%, or prior history of PCI/CABG were excluded from the study. They were divided into two groups on the basis of renal function; group I (n=55): impaired renal function group (eGFR < 90 ml/ min/1.73m 2 ) and group II (n=55): normal renal function group (eGFR > 90 ml/min/1.73m 2 Vessel score: This is the number of vessel with a significant stenosis (for left main coronary artery 50% or greater and for others 70% or greater reduction in luminal diameter. coronary artery stenosis <70% in major epicardial coronary arteries were termed non-obstructive CAD). 12 Score ranges from 0 to 3, depending on the number of vessel involved. Left main coronary artery will be scored as single vessel disease. 13 Score 0 = no vessel involvement/non obstructive CAD. Score 1 = single vessel involvement. Score 2 = double vessel involvement. Score 3 = triple vessel involvement Gensini score: The Gensini score was developed by Gensini and takes into consideration the geometrical severity of lesions by angiography, the cumulative effects of multiple obstructions and the significance of jeopardized myocardium. A nonlinear score is assigned to each lesion based on the severity of stenosis as indicated by the reduction of lumen diameter. A multiplier is applied to each lesion score based upon its location in the coronary tree depending on the functional significance of the area supplied by that segment. The final Gensini score is the sum of the lesion scores. 14 According to Gensini score CAD is categorized as mild (1-10), moderate (11-50) and severe (>50). 15 
Statistical methods:
The numerical data obtained from the study were analyzed and significance of differences were estimated by using statistical methods. The SPSS Statistical Software (16.0 version, SPSS Inc., Chicago, Illinois, USA) was used for data analysis. Continuous variables were expressed in mean & standard deviation and categorical variables as frequency and percentage. Quantitative variables were analyzed by Student's t-test and ANOVA and Categorical variables were analyzed by chi-square test and Fisher's exact test as applicable. To test association between impaired renal function and coronary artery disease severity pearson's and Spearman's rank order correlation test used. Univariate and multivariate logistic regression analysis were done to evaluate the independent predictors of severe CAD. The odds ratio (OR) and 95% confidence interval were calculated. p value of less than 0.05 was considered as significant.
Results:
The mean age of patients of group-I is 55.60 and group-ÉÉ is 49.40 years and the difference is statistically significant. Male:Female ratio is 10:1. BMI is significantly low in group-É. Among the conventional CVD risk factors, hypertension and dyslipidaemia are significantly high in group-É. No significant difference between two groups was found in case of smoking and family history of CAD. Study groups were well matched in terms of drug history ( Table-I significant difference between two group (Table-II) .
CAD was mild in 9.1% patients in group I and 23.6% patients in group II and mild CAD was significantly low in group I (p=0.04). Moderate CAD was found in 60% and 69.1% patients in group I and group II respectively with insignificant difference (p=0.31). Severe CAD was found in 30.9% patients in group I and 7.3% patients in group II and was significantly higher in group I (p=0.001) ( Table-III) . In multivariate logistic regression analysis, after adjustment of factors, Hypertension, dyslipidemia, Serum creatinine and eGFR were found the independent predictors of severe CAD with ORs being 3.71, 4.95, 5.36 and 5.73 respectively.
Discussion:
The mean age of group É patients was 55.6±7.5 years and that of group ÉÉ was 49.4±6.6 years (p<0.05). In a similar study mean age was 67.8 ± 9.0 years in impaired renal function group and 52.5 ± 10.3 years in normal renal function group and difference was statistically significant ( p <0.001). 18 It was evident from the study that patients with renal impairment tended to be older than those with normal renal function. Chronic kidney disease (CKD) is a growing public health concern that overwhelmingly affects older adults.
Body mass index of patients of group I and group II were 22.7 ±1.2 kg/m 2 and 24.1±2.1 kg/m 2 respectively and difference was statistically significant (P <0.05). This was consistent with the findings that patients with CKD had lower body mass index levels than those with normal renal function (23.5 ±0.2 kg/m 2 vs. 24.0±.02 kg/ m 2 ). 9 It might indicate malnutrition due to low protein diet, uremic toxicity and inflammation in patients with renal impairment. Among the conventional risk factors of CAD, diabetic patients were excluded from study; smoking & family history of CAD were found non-significant but hypertension & dyslipidaemia were significantly high in impaired renal function group. Though dyslipidaemia was found statistically significant in risk factor analysis, here lipoproteins level were well controlled which might be due to lipid lowering therapy with statin.
In our study the mean serum creatinine was 1.34±0.3 mg/dl in group É and 0.8±0.1 mg/dl in group II and the difference was statistically significant (P<0.05). In a similar study 18 mean serum creatinine was 1.47 ± 0.91 in decreased renal function group and 0.87 ± 0.17 in patients with normal renal function. In comparison with our study, mean serum creatinine was high in decreased GFR group which might be explained as they included patients with end-stage renal disease but we didn't.
The mean eGFR of subjects with insignificant coronary artery disease was 100.1±14.5 ml/min/ 1.73m 2 In our study correlation co-efficient between eGFR and vessel score was r=-0.30 (p<0.05) and correlation co-efficient between eGFR and Gensini score was r =-0.65 (p<0.05). In a similar study 18 
